Kagan and Soai Won 2026 Nobel Prize in Chemistry

The Royal Swedish Academy of Sciences honored the pair for their advancements in asymmetric organic synthesis.

Updated on Oct. 7, 2026 in Chemistry

A close-up view of clear chemical glassware in a clean, sterile scientific laboratory environment.
Henri B. Kagan and Kenso Soai were awarded the 2026 Nobel Prize in Chemistry for their transformative research in asymmetric organic synthesis. AI Illustration. Upload story photo >

Henri B. Kagan and Kenso Soai have been awarded the 2026 Nobel Prize in Chemistry. The prestigious honor recognizes their pioneering discovery of non-linear effects and autocatalysis in asymmetric organic synthesis.

Why it matters

Their research into asymmetric synthesis has fundamentally changed how chemists create mirror-image molecules, which is critical for the development of modern pharmaceuticals. This work allows for more efficient and precise chemical production processes.

The prize includes a total purse of 12 million krona, equivalent to approximately $1.2 million. The award is based on the recipients' specific breakthroughs in defining non-linear effects within catalytic chemical reactions.

The players

Henri B. Kagan

He is a renowned chemist recognized for his seminal contributions to asymmetric synthesis.

Kenso Soai

He is a prominent chemist whose research focuses on autocatalytic processes and chirality.

Royal Swedish Academy of Sciences

This independent organization is responsible for selecting the laureates for the Nobel Prizes in Physics and Chemistry.

The details

The Royal Swedish Academy of Sciences selected Kagan and Soai for their development of methods that control the structural handedness of molecules during chemical reactions. By utilizing autocatalysis, their work enables the self-amplification of desired molecular configurations.

Timeline

  1. October 7, 2026: The Nobel Prize in Chemistry recipients were formally announced.

Deeper Dive

This award follows the historical trajectory set by the 2001 Nobel Prize in Chemistry for asymmetric catalysis. It honors a crucial expansion of that research by recognizing the discovery of non-linear effects and autocatalysis.

The methodologies developed by Kagan and Soai enable more efficient production of high-purity chiral drugs, which can reduce side effects and production costs for common medications. This advancement facilitates the creation of safer, more effective treatments for patients worldwide.

The takeaway

The recognition of Kagan and Soai highlights the critical importance of asymmetric synthesis in modern scientific and industrial applications. Aspiring researchers can look to these developments as a primary model for how theoretical catalytic breakthroughs translate into practical medical advancements.

Further reading

For more information on the history of this discipline, visit the Chemistry section.